Protein Detection & Quantification Market Is Anticipated To Grow Quickly Due To Rising Demand For Protein Quantification In Laboratories Till 2025: Grand View Research, Inc.
The global protein detection & quantification market is
expected to reach USD 3.00 billion by 2025, according to a new report by Grand
View Research, Inc. Introduction of assay methods that enable protein
estimation at lower limits of concentration in order to monitor the changes is
expected to drive growth in the coming years.
Governments are encouraging the
research activities by raising funds in the field of proteomics industry and
thus the protein detection and quantification market is anticipated to grow at
a significant pace in the coming years. Presence of organizations such as the
Human Proteome Organization, National Cancer Institute (NCI) and Genomic Health
Inc. promotes funding to support R&D and product development exercises
pertaining to the field of proteomics.
Growing need to understand
chronic diseases at a molecular level and develop therapeutic solutions is
expected to encourage these organizations to fund research and development
programs. In addition, Public Health Genomics at the National Cancer Institute
(NCI) promotes the integration of personalized medicine and genomics into
public health cancer research in an attempt to reduce the burden of cancer
across the globe
Although technological
advancements continue to take place for simplification protein estimation, high
cost of technology and assays are anticipated to restrict the usage of these
assays and technologies under certain circumstances. For instance, Mass
Spectroscopy (MS) which are often used for functional proteomics is considered
expensive and slow by researchers. In targeted MS, custom antibodies are
required for each target to perform immunoaffinity enrichment of peptides. This
process is observed to be expensive as well as lengthy.
Germany protein detection
& quantification market by end-use, 2014 - 2025 (USD Million)
Browse full research report on
Protein
Detection & Quantification Market
Further key findings from
the report suggest:
- Colorimetry
dominated with the largest share sue to presence of significant usage of
the reagents and solutions for laboratory analysis
- Immunological
methods and spectrometric methods are anticipated to grow at similar rates
and exhibit fastest Y-o-Y growth
- Advancements
in these segments such as FTIR and SMCxPRO technology are attributive for
the projected growth rate
- Consumables
accounted for the largest share due to wider availability and usage of
kits and reagents
- Clinical
diagnosis is expected to register fastest progress in the coming years as
a result of rising adoption these methods
- Substantial
use of technology in target identification and other steps of drug
discovery is attributive for the largest share of drug discovery as an
application of estimation of these biomolecules
- Academic
organizations dominated with respect to use of these protocols and
clinical diagnostic labs anticipated to witness fastest progress
- North
American region accounted for the largest share as a consequence of large
number of proteomics projects implemented herein
- Asia Pacific
market is expected to grow at the most lucrative pace due to changing
health care infrastructure in this region which drives the demand for
these products
- Key players
operating include PerkinElmer Inc, GE Healthcare, Inanovate, Thermo Fisher
Scientific, Danaher, Merck & Co., Inc., Bio-Rad Laboratories, Inc.,
Shimadzu Corporation, and RayBiotech, Inc.
- These
companies are engaged in collaborations, mergers & acquisitions for
the new product launches that rely on the conventional technology but
provide novel application in the field of proteomics
For
more information: http://www.grandviewresearch.com
Comments
Post a Comment